Stuart Scott Memorial Cancer Research Fund

The V Foundation for Cancer Research established the Stuart Scott Memorial Cancer Research Fund in memory of celebrated ESPN sportscaster Stuart Scott after he passed away on January 4, 2015.

"This whole fight . . . is not a solo venture. This is something that requires support." - Stuart Scott

Stuart had always been a dedicated friend to the V Foundation and an inspiration to athletes, fans and fellow broadcasters. When he was diagnosed with cancer, this didn’t change. Stuart was a champion for cancer research and became involved in a clinical trial himself as his fight continued.

Stuart was especially driven to improve outcomes for African Americans and other minorities disproportionately with cancer, and he became a passionate voice on their behalf. According to the Centers for Disease Control and Prevention’s data, there are many examples of cancer disparities among minority populations in the U.S. The Stuart Scott Memorial Cancer Research Fund ensures essential resources are dedicated to these populations.

To date, more than $4 million in grants have been awarded via the Stuart Scott Fund. These grants continue to support scholars and research dedicated to the aggressiveness, therapeutic responsiveness and ultimate outcomes experienced by cancer patients from different ethnic populations.

In July 2014, Stuart received the Jimmy V Perseverance Award at the ESPY Awards. During his remarkable speech, he said, “When you die, it does not mean you lose to cancer. You beat cancer by how you live, why you live and in the manner in which you live.” Stuart passed away less than six months later at the age of 49. His extraordinary impact will continue to be felt for years to come.

"When you die, it does not mean that you lose to cancer. You beat cancer by how you live, why you live and in the manner in which you live." - Stuart Scott

Stuart Scott Fund Translational Grant Recipients

Sanford Markowitz, M.D., Ph.D.
Case Comprehensive Cancer Center
Cleveland, OH
Interpreting the Mutational Signature of African American Colorectal Cancers
Funded by the Stuart Scott Memorial Fund

Ralph Weissleder, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Boston, MA
Enhanced holographic diagnostics and profiling of breast cancer using smartphones for point-of-care use
Funded by the Stuart Scott Memorial Fund

Matthew Meyerson, M.D., Ph.D.
Dana-Farber Cancer Institute
Boston, MA
The contribution of germline genomic variation to EGFR mutation frequency in non-small cell lung cancers in Latin American populations: implications for cancer risk prediction, screening and intervention.
Funded by the Stuart Scott Memorial Fund

Adam Murphy, M.D.
Robert H. Lurie Comprehensive Cancer Center, Northwestern University
Chicago, IL
A Prospective Validation of a Prostate Cancer Biomarker in African American Men
Funded by the Stuart Scott Memorial Cancer Research Fund

 

Stuart Scott Fund V Scholar Grant Recipients

Akinyemi Ojesina, M.D., Ph.D.
University of Alabama at Birmingham Comprehensive Cancer Center
Birmingham, AL
Metatranscriptomic Biomarkers for Predicting Tumor Recurrence
Funded by the Stuart Scott Memorial Fund

Miguel Rivera, M.D.
Massachusetts General Hospital Cancer Center
Charleston, MA
Function of the protein kinase VRK1 in Ewing Sarcoma
Funded by the Stuart Scott Memorial Fund

Raymond Blind, Ph.D.
Vanderbilt University School of Medicine
Nashville, TN
Nuclear lipids as hepatocellular carcinoma biomarkers
Funded by the Stuart Scott Memorial Cancer Research Fund

Gianna Hammer, Ph.D.
Duke Cancer Institute
Durham, NC
Microbiota induced upregulation of PDL√ on intestinal dendritic cells in intestinal tumorigenesis
Funded by the Stuart Scott Memorial Cancer Research Fund

Marcela Maus, M.D., Ph.D.
Massachusetts General Hospital Cancer Center
Boston, MA
Design and pre-clinical evaluation of CAR T cells for myeloma
Funded by the Stuart Scott Memorial Cancer Research Fund

Michelle Mendoza, Ph.D.
Huntsman Cancer Institute, University of Utah
Salt Lake City, UT
Differential Regulation of Tumor Invasion by RSK Family Isoforms
Funded by the Stuart Scott Memorial Cancer Research Fund

 

Stuart Scott Fund Designated Grant Recipients

Jeffrey Clarke, M.D.
Duke University
Durham, NC
Identification of Genetic Determinates for Disparities in African American Patients with Non-Small Cell Lung Cancer
Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds

Chad Pecot, M.D.
The University of North Carolina at Chapel Hill
Chapel Hill, NC
Targeting the Immune Microenvironment to Treat Squamous Cancers
Funded in partnership with the Lung Cancer Initiative of North Carolina, utilizing Stuart Scott Memorial Cancer Fund matching funds

Read more about Dr. Pecot’s research